Quidditas Therapeutics

Quidditas Therapeutics Develops Genome-Editing-Based Therapies for Genetic Diseases, Oncology, and Organ Transplantation. The company’s technology enables absolute gene recombination, offering off-the-shelf treatments for diseases once considered incurable, empowering healthcare professionals to address genetic disorders.